U.S. License Holder:
Novo Nordisk Inc.
Date of License:
NORDITROPIN FLEXPRO (somatropin) is a recombinant human growth hormone indicated for:
Pediatric: Treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Noonan syndrome, short stature associated with Turner syndrome, short stature born small for gestational age (SGA) with no catch-up growth by age 2 to 4 years, Idiopathic Short Stature (ISS), and growth failure due to Prader-Willi Syndrome:
Adult: Replacement of endogenous GH in adults with growth hormone deficiency.